| SCARB2 |
|---|
 |
| Identifiers |
|---|
| Aliases | SCARB2, AMRF, CD36L2, EPM4, HLGP85, LGP85, LIMP-2, LIMPII, SR-BII, scavenger receptor class B member 2 |
|---|
| External IDs | OMIM: 602257; MGI: 1196458; GeneCards: SCARB2 |
|---|
|
|
| Gene location (Mouse) |
|---|
%3C%2Ftitle%3E%3Cdefs%3E%3CclipPath%20id%3D%22alt-text-clip%22%3E%3Crect%20x%3D%220%22%20y%3D%220%22%20width%3D%22100%25%22%20height%3D%22100%25%22%20%2F%3E%3C%2FclipPath%3E%3C%2Fdefs%3E%3Crect%20width%3D%22100%25%22%20height%3D%22100%25%22%20fill%3D%22transparent%22%2F%3E%3Cg%20clip-path%3D%22url(%23alt-text-clip)%22%3E%3Ctext%20x%3D%2250%25%22%20y%3D%2250%25%22%20text-anchor%3D%22middle%22%20dominant-baseline%3D%22middle%22%20fill%3D%22%2354595d%22%20font-size%3D%2216%22%20font-family%3D%22sans-serif%22%3EChromosome%205%20(mouse)%3C%2Ftext%3E%3C%2Fg%3E%3C%2Fsvg%3E) | | Chr. | Chromosome 5 (mouse) |
|---|
| | Band | 5|5 E2 | Start | 92,589,173 bp |
|---|
| End | 92,654,692 bp |
|---|
|
| RNA expression pattern |
|---|
| Bgee | | Human | Mouse (ortholog) |
|---|
| Top expressed in | - inferior ganglion of vagus nerve
- subthalamic nucleus
- germinal epithelium
- superior vestibular nucleus
- external globus pallidus
- pons
- pars reticulata
- pars compacta
- lactiferous duct
- trigeminal ganglion
|
| | Top expressed in | - transitional epithelium of urinary bladder
- iris
- carotid body
- ciliary body
- median eminence
- right lung
- arcuate nucleus
- ventral tegmental area
- deep cerebellar nuclei
- dorsal tegmental nucleus
|
| | More reference expression data |
|
|---|
| BioGPS | |
|---|
|
|
|
| Wikidata |
|
Lysosomal integral membrane protein 2 (LIMP-2) is a protein that in humans is encoded by the SCARB2 gene. LIMP-2 is expressed in brain, heart, liver, lung and kidney, mainly in the membrane of lysosome organelles; however, in cardiac muscle, LIMP-2 is also expressed at intercalated discs. LIMP-2 in a membrane protein in lysosomes that functions to regulate lysosomal/endosomal transport. Mutations in LIMP-2 have been shown to cause Gaucher disease, myoclonic epilepsy, and action myoclonus–renal failure syndrome. Abnormal levels of LIMP-2 have also been found in patients with hypertrophic cardiomyopathy.